Viewing StudyNCT02130882



Ignite Creation Date: 2024-05-06 @ 2:50 AM
Last Modification Date: 2024-10-26 @ 11:23 AM
Study NCT ID: NCT02130882
Status: UNKNOWN
Last Update Posted: 2022-02-08
First Post: 2014-04-03

Brief Title: Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institutes of Health Clinical Center CC

Organization Data

Organization: National Institutes of Health Clinical Center CC
Class: NIH
Study ID: 140081
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
AstraZeneca INDUSTRY